These results support the conclusion that Gα12 overexpression causes miR-122 dysregulation, promoting c-Met induction, which may deteriorate the prognosis, recurrence-free and overall survival rates of HCC patients. This evidence concerns the gene MET and hepatocellular carcinoma.